Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese

Clinical and Experimental Nephrology

Volumn 19, Issue 5, 2015, Pages 797-803

  Hayashi, Norifumi ^a   Akiyama, Shin’ichi ^b   Okuyama, Hiroshi ^a   Matsui, Yuki ^a   Adachi, Hiroki ^a   Yamaya, Hideki ^a   Maruyama, Shoichi ^b   Imai, Enyu ^b   Matsuo, Seiichi ^b   Yokoyama, Hitoshi ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Electron microscopic findings; IgG subclass staining; Membranous nephropathy; Phospholipase A2 receptor; Western blotting

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; M TYPE PHOSPHOLIPASE A2 RECEPTOR; MIZORIBINE; PHOSPHOLIPASE A2 RECEPTOR; STEROID; UNCLASSIFIED DRUG; PLA2R1 PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE (PEOPLE); MALE; MEMBRANOUS GLOMERULONEPHRITIS; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; GENETICS; GLOMERULUS; GLOMERULUS FILTRATION RATE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOGLOBULIN G; KAPLAN-MEIER ESTIMATE; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROTEINURIA; RECEPTORS, PHOSPHOLIPASE A2; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84944160482     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1064-0     Document Type: Article

References (26)

1. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010;56:157–67.
2. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.
3. Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol. 2012;23:1735–43.
4. Hofstra JM, Beck LH Jr, Beck DM, et al. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6:1286–91.
5. Beck LH Jr, Fervenza FC, Beck DM, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22:1543–50.
6. Hoxha E, Kneissler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82:797–804.
7. Svobodova B, Honsova E, Ronco P, et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transpl. 2013;28:1839–44.
8. Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400–7.
9. Yokoyama H, Goshima S, Wada T, et al. The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Nephrol Dial Transpl. 1999;14:2379–86.
10. Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 2004;65:148–53.
11. Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741–6.
12. Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22:1137–43.
13. Oh YJ, Yang SH, Kim DK, et al. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One. 2013;8:e62151.
14. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011;364:689–90.
15. Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26:709–15.
16. Prunotto M, Carnevali ML, Candiano G, et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol. 2010;21:507–19.
17. Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transpl. 2012;27:1931–7.
18. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transpl. 2004;19:574–9.
19. Imai H, Hamai K, Komatsuda A, et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997;51:270–6.
20. Debiec H, Hanoy M, Francois A, et al. Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor. J Am Soc Nephrol. 2012;23:1949–54.
21. Salant DJ. Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy? J Am Soc Nephrol. 2013;24:525–8.
22. Kuroki A, Iyoda M, Shibata T, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005;68:302–10.
23. Aalberse RC, Stapel SO, Schuurman J, et al. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39:469–77.
24. Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol. 2013;26:799–805.
25. Rahimi S, Qian Z, Layton J, et al. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transpl. 2004;4:326–34.
26. Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25:1357–66.